FDAnews
www.fdanews.com/articles/75412-nektar-in-pact-to-acquire-aerogen

NEKTAR IN PACT TO ACQUIRE AEROGEN

August 16, 2005

Nektar Therapeutics said Monday it signed a definitive agreement to acquire Aerogen Inc. in a deal worth about $32 million. Nektar (NKTR: news, chart, profile) , a San Carlos, Calif.-based drug-delivery developer, said it will pay $8 million in cash and about $24 million in stock, while retaining the option of paying the full buyout price in cash. Common shares of Aerogen (AEGN: news, chart, profile) are traded on the pink sheets. Under the terms of the deal, each Aerogen common share will be exchanged for about 75 cents per share, while each Aerogen A-1 preferred share will be exchanged for approximately $29.03 a share.

Market Watch (http://www.marketwatch.com/news/yhoo/story.asp?source=blq/yhoo&siteid=yhoo&dist=yhoo&guid=%7BEC186717%2D1510%2D4CAD%2DB5A8%2D733D078488C9%7D)